Human ARHGAP24/FILGAP/p73 ORF/cDNA clone-Lentivirus particle (NM_001025616)

Cat. No.: vGMLP004338

Pre-made Human ARHGAP24/FILGAP/p73 Lentiviral expression plasmid for ARHGAP24 lentivirus packaging, ARHGAP24 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to ARHGAP24/FILGAP products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP004338 Human ARHGAP24 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP004338
Gene Name ARHGAP24
Accession Number NM_001025616
Gene ID 83478
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 2247 bp
Gene Alias FILGAP,p73,p73RhoGAP,RC-GAP72,RCGAP72
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGAGGAGAACAATGACTCCACGGAGAACCCCCAACAAGGCCAAGGGCGGCAGAATGCCATCAAGTGTGGGTGGCTGAGGAAGCAAGGAGGCTTTGTCAAGACTTGGCATACTCGCTGGTTTGTGCTCAAGGGGGATCAGCTCTATTATTTCAAAGATGAAGATGAAACCAAGCCCTTGGGTACTATTTTTCTGCCTGGAAATAAAGTTTCTGAGCATCCCTGCAATGAAGAGAACCCAGGGAAGTTCCTTTTTGAAGTAGTTCCAGGAGGCGATCGAGATCGGATGACAGCAAATCATGAAAGCTACCTCCTCATGGCAAGCACCCAGAATGATATGGAAGACTGGGTGAAGTCAATCCGCCGAGTCATATGGGGACCTTTCGGAGGAGGCATTTTTGGACAGAAACTGGAGGATACTGTTCGTTATGAGAAGAGATATGGGAACCGTCTGGCTCCGATGTTGGTGGAGCAGTGCGTGGACTTTATCCGACAAAGGGGGCTGAAAGAAGAGGGTCTCTTTCGACTGCCAGGCCAGGCTAATCTTGTTAAGGAGCTCCAAGATGCCTTTGACTGTGGGGAGAAGCCATCATTTGACAGCAACACAGATGTACACACGGTGGCATCACTTCTTAAGCTGTACCTCCGAGAACTTCCAGAACCAGTTATTCCTTATGCGAAGTATGAAGATTTTTTGTCATGTGCCAAACTGCTCAGCAAGGAAGAGGAAGCAGGTGTTAAGGAATTAGCAAAGCAGGTGAAGAGTTTGCCAGTGGTAAATTACAACCTCCTCAAGTATATTTGCAGATTCTTGGATGAAGTACAGTCCTACTCGGGAGTTAACAAAATGAGTGTGCAGAACTTGGCAACGGTCTTTGGTCCTAATATCCTGCGCCCCAAAGTGGAAGATCCTTTGACTATCATGGAGGGCACTGTGGTGGTCCAGCAGTTGATGTCAGTGATGATTAGCAAACATGATTGCCTCTTTCCCAAAGATGCAGAACTACAAAGCAAGCCCCAAGATGGAGTGAGCAACAACAATGAAATTCAGAAGAAAGCCACCATGGGGCAGTTACAGAACAAGGAGAACAATAACACCAAGGACAGCCCTAGTAGGCAGTGCTCCTGGGACAAGTCTGAGTCACCCCAGAGAAGCAGCATGAACAATGGATCCCCCACAGCTCTATCAGGCAGCAAAACCAACAGCCCAAAGAACAGTGTTCACAAGCTAGATGTGTCTAGAAGCCCCCCTCTCATGGTCAAAAAGAACCCAGCCTTTAATAAGGGTAGTGGGATAGTTACCAATGGGTCCTTCAGCAGCAGTAATGCAGAAGGTCTTGAGAAAACCCAAACCACCCCCAATGGGAGCCTACAGGCCAGAAGGAGCTCTTCACTGAAGGTATCTGGTACCAAAATGGGCACGCACAGTGTACAGAATGGAACGGTGCGCATGGGCATTTTGAACAGCGACACACTCGGGAACCCCACAAATGTTCGAAACATGAGCTGGCTGCCAAATGGCTATGTGACCCTGAGGGATAACAAGCAGAAAGAACAAGCTGGAGAGTTAGGCCAGCACAACAGACTGTCCACCTATGATAATGTCCATCAACAGTTCTCCATGATGAACCTTGATGACAAGCAGAGCATTGACAGTGCTACCTGGTCCACTTCCTCCTGTGAAATCTCCCTCCCTGAGAACTCCAACTCCTGTCGCTCTTCTACCACCACCTGCCCAGAGCAAGACTTTTTTGGGGGGAACTTTGAGGACCCTGTTTTGGATGGGCCCCCGCAGGACGACCTTTCCCACCCCAGGGACTATGAAAGCAAAAGTGACCACAGGAGTGTGGGAGGTCGAAGTAGTCGTGCCACCAGTAGCAGTGACAACAGTGAGACATTTGTGGGCAACAGCAGCAGCAACCACAGTGCACTGCACAGTTTAGTTTCCAGCCTGAAACAGGAAATGACCAAACAGAAGATAGAGTATGAGTCCAGGATAAAGAGCTTAGAACAGCGAAACTTGACTTTGGAAACAGAAATGATGAGCCTCCATGATGAACTGGATCAGGAGAGGAAAAAGTTCACAATGATAGAAATAAAAATGCGAAATGCCGAGCGAGCAAAAGAAGATGCCGAGAAAAGAAATGACATGCTACAGAAAGAAATGGAGCAGTTTTTTTCCACGTTTGGAGAACTGACAGTGGAACCCAGGAGAACCGAGAGAGGAAACACAATATGGATTCAGTGA
ORF Protein Sequence MEENNDSTENPQQGQGRQNAIKCGWLRKQGGFVKTWHTRWFVLKGDQLYYFKDEDETKPLGTIFLPGNKVSEHPCNEENPGKFLFEVVPGGDRDRMTANHESYLLMASTQNDMEDWVKSIRRVIWGPFGGGIFGQKLEDTVRYEKRYGNRLAPMLVEQCVDFIRQRGLKEEGLFRLPGQANLVKELQDAFDCGEKPSFDSNTDVHTVASLLKLYLRELPEPVIPYAKYEDFLSCAKLLSKEEEAGVKELAKQVKSLPVVNYNLLKYICRFLDEVQSYSGVNKMSVQNLATVFGPNILRPKVEDPLTIMEGTVVVQQLMSVMISKHDCLFPKDAELQSKPQDGVSNNNEIQKKATMGQLQNKENNNTKDSPSRQCSWDKSESPQRSSMNNGSPTALSGSKTNSPKNSVHKLDVSRSPPLMVKKNPAFNKGSGIVTNGSFSSSNAEGLEKTQTTPNGSLQARRSSSLKVSGTKMGTHSVQNGTVRMGILNSDTLGNPTNVRNMSWLPNGYVTLRDNKQKEQAGELGQHNRLSTYDNVHQQFSMMNLDDKQSIDSATWSTSSCEISLPENSNSCRSSTTTCPEQDFFGGNFEDPVLDGPPQDDLSHPRDYESKSDHRSVGGRSSRATSSSDNSETFVGNSSSNHSALHSLVSSLKQEMTKQKIEYESRIKSLEQRNLTLETEMMSLHDELDQERKKFTMIEIKMRNAERAKEDAEKRNDMLQKEMEQFFSTFGELTVEPRRTERGNTIWIQ

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP2349-Ab Anti-ARHGAP24 monoclonal antibody
    Target Antigen GM-Tg-g-IP2349-Ag ARHGAP24 protein
    ORF Viral Vector pGMLP004338 Human ARHGAP24 Lentivirus plasmid
    ORF Viral Vector vGMLP004338 Human ARHGAP24 Lentivirus particle


    Target information

    Target ID GM-IP2349
    Target Name ARHGAP24
    Gene ID 83478, 231532, 699614, 305156, 101080454, 478463, 539902, 100052555
    Gene Symbol and Synonyms 0610025G21Rik,ARHGAP24,DR-NR#2,FILGAP,p73,p73RhoGAP,RC-GAP72,RCGAP72
    Uniprot Accession Q8N264
    Uniprot Entry Name RHG24_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000138639
    Target Classification Not Available

    This gene encodes a Rho-GTPase activating protein, which is specific for the small GTPase family member Rac. Binding of the encoded protein by filamin A targets it to sites of membrane protrusion, where it antognizes Rac. This results in suppression of lamellae formation and promotion of retraction to regulate cell polarity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.